J R Wunderlich - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J R Wunderlich

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

International Journal of Clinical & Laboratory Research|January 11, 1992

Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapyJ R Wunderlich, D Mezzanzanica, M A Garrido, et al.

Immunobiology|August 1, 1992

Targeting of anti-tumor responses with bispecific antibodiesD M Segal, J H Qian, D Mezzanzanica, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1995

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivoM B Moreno, J A Titus, M S Cole, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Nature Medicine|March 21, 1998

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Pageof 6

Search research articles

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

International Journal of Clinical & Laboratory Research|January 11, 1992

Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapyJ R Wunderlich, D Mezzanzanica, M A Garrido, et al.

Immunobiology|August 1, 1992

Targeting of anti-tumor responses with bispecific antibodiesD M Segal, J H Qian, D Mezzanzanica, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1995

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivoM B Moreno, J A Titus, M S Cole, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Nature Medicine|March 21, 1998

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Pageof 6